News

FECCIA

FECCIA response to the Commission’s proposal for a revision of the European Works Council Directive 2009/38/EC

Successful kick-off of the #ChemSkills blueprint!

Congratulations and a big thank you to Anni, Emma, Chiara and Eleonora for a successful kick-off of the #ChemSkills blueprint!

Other

CEFIC Publishes 2024 Facts and Figures Report

CEFIC , the European Chemical Industry Council, has published its 2024 Facts & Figures report, which reinforces the need to take bold and urgent action to secure Europe’s industrial future, not only to implement the Green Deal but also to prevent further de-industrialization in Europe.

Heraeus Acquires Umicore’s Platinum API Business outside of South America

In a move to strengthen its position and product portfolio, Heraeus has announced the acquisition of Umicore's business with platinum-containing active pharmaceutical ingredients (APIs) outside South America. With immediate effect, the business is transferred to Heraeus Precious Metals, the group's precious metals division.

BASF Divests Food and Health Performance Ingredients Business to Louis Dreyfus Company

BASF has signed a binding agreement to sell its Food and Health Performance Ingredients business, including the production site in Illertissen, Germany, to Louis Dreyfus Company (LDC), a Dutch merchant and processor of agricultural goods.

GSK May Acquire Cancer Specialist IDRx for $1 Billion

Treatment for Digestive System Cancer


09.01.2025 - In a move to expand its oncology business, GSK is nearing a $1 billion deal to buy a US biotech developing a treatment for rare gastrointestinal tumors.

Roche to Buy Poseida Therapeutics for $1.5 Billion

Roche has entered into a definitive merger agreement to acquire Poseida Therapeutics, a US clinical-stage biopharmaceutical company developing donor-derived CAR-T cell therapies, in a deal valued at approximately $1.5 billion.

Ineos Enterprises Sells Ineos Composites for €1.7 Billion

Ineos Enterprises has agreed to sell the Ineos Composites business to KPS Capital Partners for an estimated €1.7 billion.

Sanofi to Invest $1 Billion in New Insulin Manufacturing Site in China

Sanofi plans to invest around €1 billion ($1.1 billion) in the construction of a new insulin production facility in Beijing – the company's largest single investment in China to date. This was reported by Reuters and other news agencies.

Arkema Acquires Dow's Flexible Packaging Laminating Adhesives Business

Arkema recently finalized the acquisition of Dow’s flexible packaging laminating adhesives business. This acquisition will significantly expand Arkema's portfolio of solutions for flexible packaging, positioning the company as a key player in this attractive market.

Novartis Acquires Kate Therapeutics for $1.1 Billion

Swiss pharmaceutical giant Novartis has acquired Kate Therapeutics for $1.1 billion. The San Diego, US-headquartered preclinical stage biotechnology company develops adeno-associated virus (AAV)-based gene therapies to treat inherited neuromuscular diseases.